News

Before COVID-19, half of families with employer-sponsored insurance delayed care or avoided filling a prescription. Recent data shows consumers face barriers to care.

Lives can be saved, physician burnout and waste can be reduced, and drug costs can decrease by achieving medication optimization through comprehensive medication management.

Shielding means staying at home and limiting contact with members of the household. Research also calls into question on how effective it is in reducing the incidence of COVID-19.

Content of this article was sponsored by Arbor Pharmaceuticals, LLC. Copyright 2020. This Managed Healthcare Executive® publication provides key information regarding a review by Faraone, et al, which was originally published in the Journal of the American Academy of Child & Adolescent Psychiatry (doi: 10.1016/j.jaac.2019.06.012). The authors of the original review are Stephen V. Faraone, PhD; Anthony L. Rostain, MD; C. Brendan Montano, MD; Oren Mason, MD; Kevin M. Antshel, PhD; Jeffrey H. Newcorn, MD. Please consult the full published review for complete information.

Preliminary findings by Case Western researchers point to kallikrein-related peptidase 6 as possible culprit in the development of psoriatic arthritis.

In a busy week, FDA approved ground-breaking therapies in hematologic cancers and issued Orphan Drug designations in areas of significant unmet need.

COVID-19 spotlights the threat that cardiovascular disease poses to Americans; new technology may help address risk factors at the population health level.

Artificial intelligence and machine learning can take on simple tasks in healthcare so people can focus on collaboration and work on a higher cognitive level.

As it has done with so much else in healthcare, COVID-19 dominated our 2020 annual pharmacy survey. The disease was addressed in 10 of our 13 areas we covered, either within the question itself or as a possible answer. Third of three parts. See more in our Surveys tab.

Now is the time to take serious action to reform wasteful hospital practices and strengthen the healthcare supply chain. The high cost of American healthcare has topped headlines for years.

Advocates say a number of regulatory changes could help bring more of these products on to the market.

As it has done with so much else in healthcare, COVID-19 dominated our 2020 annual pharmacy survey. The disease was addressed in 10 of our 13 areas we covered, either within the question itself or as a possible answer. Second of three parts. See more in our Surveys tab.

Founder of the Camden Coalition and a SDOH pioneer is looking to establish a primary care clinic in southern New Jersey.

As several COVID-19 vaccine candidates are now in the late phase of clinical trials, MHE is sharing a few stories that have covered the infamous virus' vaccine development journey.

Briana Contreras speaks with Dan Knecht, Vice President of Clinical Product at CVS Health about telehealth, patient access, CVS minute clinics and Path to Better Health.

Underrepresentation of blacks in clinical trials is garnering special attention.

Managed Healthcare Executive® (MHE) interviewed Jeff Hawkins, president and CEO of Truvian Sciences, about how Truvian received an Emergency Use Authorization (EUA) from FDA for Easy Check COVID-19 IgM/IgG antibody test.

As it has done with so much else in healthcare, COVID-19 dominated our 2020 annual pharmacy survey. The disease was addressed in 10 of our 13 areas we covered, either within the question itself or as a possible answer. First of three parts. See more in our Surveys tab.

Providers are under immense financial pressure because of COVID-19. More than ever, health systems, hospitals and physician practices are assuming the role of a bank, financing the cost of healthcare.

A strong, up-to-date compliance program should be part of a healthcare company's risk management strategy.

Senior Vice President and Chief Pharmacy Officer for Optum Rx and member of the Managed Healthcare Executive® Editorial Advisory Board, David Calabrese, provides his commentary on the future of pharmacy care services after the coronavirus pandemic.

Where some see bloat and trendiness, others see nimbleness and responsiveness.

Study allays some concern that high-deductible health plans cause people to put off care, although authors urge caution in interpreting the results.

Dr. Deepak Bhatt presents results that show Vascepa cuts the risk for surgeries to restore blood flow to the heart by a third.

Practice Fusion case spotlights how technology can be corrupted by commercial interests.

Jagdish Khubchandani, a Health Science professor at Ball State University, provides tips and reminders to help keep one of the most vulnerable populations safe during the continuous battle of COVID-19. Some tips not only include frequent hand-washing and wearing masks, but getting enough sleep is also just as important.

Biosimilar misinformation takes many forms, some of it institutionalized in the form of word usage and some of it deliberately disparaging, 2 executives of Sandoz and Boehringer Ingelheim contend.